Historique
Auteur L. GIOMMONI
Documents disponibles écrits par cet auteur (6)
Ajouter le résultat à votre sélection Affiner la recherche
This article contributes to the growing literature on the use of computer-mediated communications to research illicit markets. In it, we conduct an analysis of the British cannabis market using data crowdsourced from a publicly available platfor[...]
L. GIOMMONI ; A. AZIANI ; G. BERLUSCONI | 2017
Dans Journal of Drug Issues (Vol.47, n°2, April 2017) Article : PériodiqueIllicit drugs are trafficked across manifold borders before ultimately reaching consumers. Consequently, interdiction of cross-border drug trafficking forms a critical component of the European Union's initiative to reduce drug supplies. However[...]
L. GIOMMONI | 2024
Dans International Journal of Drug Policy (Vol.124, February 2024) Article : PériodiqueIn April 2023, the Taliban banned poppy cultivation and the trade of all narcotics. This caused a 95% reduction in opium production. Usually, that would be good news. But there is a substantial worry: synthetic opioids might fill the void left b[...]
This study estimates the retail value of the illicit drug market in Italy from a consumption-based approach. The illicit drugs considered in this analysis are heroin, cocaine, cannabis (herbal and resin), amphetamines and ecstasy. Results show t[...]
A. BERGERON ; D. DÉCARY-HÉTU ; L. GIOMMONI ; M. P. VILLENEUVE-DUBUC | 2022
Dans International Journal of Drug Policy (Vol.99, January 2022) Article : PériodiqueBackground and Aims: In the months following the onset of the COVID-19 pandemic, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA; 2020) observed an increased use of cryptomarkets, which led them to question whether cryptomark[...]
B. KILMER ; P. REUTER ; L. GIOMMONI | 2015
Dans Crime and Justice (Vol.44, December 2015) Article : PériodiqueThere has been relatively little effort at cross-national analysis of data concerning drug policy, though there is growing variation in how nations deal with illegal drugs. Systematic accounts of barriers to, and opportunities for, making compar[...]
